Superior Silybin Bioavailability in Healthy Volunteers
Launched by MEDICA SUR CLINIC & FOUNDATION · Feb 14, 2018
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
In healthy volunteers single-dose crossover study with a one week, It was assessed that volunteers were free from significant cardiac, hepatic, renal, pulmonary, neurological, gastrointestinal and hematological diseases. The volunteers clinical evaluation were determined by clinical examination
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • volunteers were free from significant cardiac, hepatic, renal, pulmonary, neurological, gastrointestinal and hematological diseases.
- • The volunteers clinical evaluation were determined by clinical examination, ECG, and the following laboratory tests: blood glucose, urea, creatinine, AST, ALT, GGT, alkaline phosphatase, total bilirubin and fractions, uric acid, total cholesterol, triglycerides, albumin and total protein, and routine urinalysis
- Exclusion Criteria:
- • Subject with HIV, HBV, HCV
- • Subject with comorbidities
- • Subject less 18 years old Subject higher 50 years old
About Medica Sur Clinic & Foundation
Medica Sur Clinic & Foundation is a leading healthcare institution based in Mexico, renowned for its commitment to advancing medical research and patient care. With state-of-the-art facilities and a multidisciplinary team of experts, Medica Sur conducts innovative clinical trials across various therapeutic areas, aiming to enhance treatment options and improve outcomes for patients. The organization emphasizes ethical research practices and patient safety, contributing to the global medical community's understanding of diseases and potential therapies. Through collaboration with industry partners, Medica Sur is dedicated to fostering advancements in healthcare and ensuring that cutting-edge treatments are accessible to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials